JPM
JPMorgan Chase & Co.
JPM has slightly lower modeled downside risk, despite its lower overall score.
PKBK
Parke Bancorp, Inc.
PKBK has a slight edge over JPM overall, supported by stronger fundamentals and stronger valuation.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
PKBK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
PKBK's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like PKBK.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over PKBK in the historical PE scenario, which offers more potential upside but is not a forecast.
PKBK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6x | $23.74 | -28% |
| Fair | 7.5x | $29.95 | -8.6% |
| Current | 8.3x | $32.76 | — |
| Expensive | 8.9x | $35.32 | +7.8% |
Historical ranges are pointers, not guarantees.
PKBK's PE is in its fair range at 8.3x.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
PKBK Forward outlook
There aren't enough analyst estimates for PKBK to show an outlook.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM's earnings per share have climbed steadily: $23.85 over the past year, up 18% from the year before, and higher year over year for 15 quarters in a row.
PKBK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $3.97 | +40% |
| Q2 2026 | $3.84 | +49% |
| Q1 2026 | $3.50 | +45% |
| Q4 2025 | $3.16 | +39% |
| Q3 2025 | $2.84 | +21% |
| Q2 2025 | $2.57 | +43% |
| Q1 2025 | $2.41 | +24% |
| Q4 2024 | $2.27 | -3.4% |
PKBK earned $3.97 per share over the past year, up 40% from the year before.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM's operating margin was 40% last quarter, about level with the same quarter a year ago.
PKBK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24M | +14% |
| Q2 2026 | $23.9M | +28% |
| Q1 2026 | $23M | +32% |
| Q4 2025 | $22.7M | +36% |
| Q3 2025 | $21M | +34% |
| Q2 2025 | $18.7M | +20% |
| Q1 2025 | $17.4M | +15% |
| Q4 2024 | $16.8M | -1.4% |
PKBK has the edge over JPM on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 68% | +3.6 points |
| Q2 2026 | 68% | +9.2 points |
| Q1 2026 | 68% | +8.6 points |
| Q4 2025 | 64% | +6.2 points |
| Q3 2025 | 64% | +4 points |
| Q2 2025 | 59% | +2.3 points |
| Q1 2025 | 59% | +3.7 points |
| Q4 2024 | 58% | -7.6 points |
PKBK has the edge over JPM on profitability, with a higher operating margin.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
PKBK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $13M | +16% |
| Q2 2026 | $5.9M | -12% |
| Q1 2026 | $13M | +96% |
| Q4 2025 | $14.4M | +70% |
| Q3 2025 | $11.2M | +20% |
| Q2 2025 | $6.7M | -24% |
| Q1 2025 | $6.6M | -21% |
| Q4 2022 | $9.1M | -0.4% |
PKBK has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over PKBK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
PKBK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +29.9K shares |
| 1 year | 0% | -5.8K shares |
| 3 years | -1.5% | -180K shares |
| 5 years | -1.4% | -173K shares |
| Available history | -0.5% | -58.8K shares |
PKBK has 12M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | $6.5M |
| Q4 2024 | $2.2M |
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
PKBK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | 2.7x | Moderate |
| Q3 2025 | 0.2x | Very low |
| Q2 2025 | 0.9x | Very low |
| Q1 2025 | 1.0x | Very low |
| Q4 2024 | 1.1x | Healthy |
PKBK has the edge over JPM on leverage, with a lower net debt burden relative to earnings.
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
PKBK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.6 | Neutral |
| Stochastic | 29.8 | Neutral |
PKBK's weekly RSI is 54 (neutral) and its Stochastic is 30 (neutral).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
PKBK PE vs Financial Services Sector
| Metric | PKBK | Sector median | Relative |
|---|---|---|---|
| PE | 8.3x | 13x | 37% below |
| PE % | 63 | 63 | Same percentile |
PKBK has the edge over JPM on valuation relative to its sector.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over PKBK on trend strength, trading above more of its moving averages.
PKBK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $32.8 | 0.1% below |
| 20 week MA | $33.5 | 2.1% below |
| 50 week MA | $30.4 | 7.7% above |
| 100 week MA | $25.4 | 29% above |
| 200 week MA | $21.9 | 50% above |
PKBK has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 50% above its 200-week average.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.
PKBK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $22.9 | $15.4 | -33% |
| 2021 | $15.4 | $21.0 | +36% |
| 2022 | $21.0 | $20.6 | -2% |
| 2023 | $20.6 | $20.3 | -1.6% |
| 2024 | $20.3 | $20.7 | +2.1% |
| 2025 | $20.7 | $24.8 | +20% |
| 2026 YTD | $24.8 | $32.8 | +32% |
PKBK has the edge over JPM on returns for 2026, with the stronger performance.